Introduction: Oculopharyngeal muscular dystrophy (OPMD) presents with progressive ptosis, dysphagia and limb girdle weakness, and is caused by expansion of a trinucleotide tandem repeat within the gene encoding poly-(A) binding protein 2.

Aim: To review the clinical manifestations of all genetically confirmed patients with OPMD in Scotland identified since 2002, and to estimate the delay between symptom onset and diagnosis. Method Retrospective case note review.

Results: The authors identified 17 patients. The commonest first symptom was ptosis at about the age of 60 years. Three to 20 years elapsed from the onset of ptosis to OPMD diagnosis. In 14 (82%) patients, dysphagia had developed by the time of diagnosis, and four (24%) out of these 14 patients with dysphagia had undergone a decade of investigation and treatment for pharyngeal problems. Thirteen patients (77%) also had symptoms of limb girdle muscle weakness. Every patient had a first-degree relative with ptosis.

Conclusions: OPMD could have been diagnosed earlier in every patient in this case series. Greater awareness of OPMD among ophthalmologists, gastroenterologists and otolaryngologists may lead to earlier diagnosis, improved management and avoidance of unnecessary investigations.

Download full-text PDF

Source
http://dx.doi.org/10.1136/bjo.2010.200378DOI Listing

Publication Analysis

Top Keywords

oculopharyngeal muscular
8
muscular dystrophy
8
limb girdle
8
patients dysphagia
8
opmd
5
patients
5
delayed diagnosis
4
diagnosis oculopharyngeal
4
dystrophy scotland
4
scotland introduction
4

Similar Publications

Oculopharyngeal muscular dystrophy (OPMD) is a rare late-onset muscle disease with progressive dysphagia as a major symptom. The Dysphagiameter is a newly developed patient-reported outcome measure (PROM) to assess the severity of dysphagia and its impact in patients with OPMD. This article reports on item reduction and a first assessment of the Dysphagiameter's psychometrics properties, in a French and English-speaking population of individuals with OPMD.

View Article and Find Full Text PDF

The median age of patients at diagnosis of mitochondrial neurogastrointestinal encephalomyopathy was 25 years. The most common neurological symptoms were leukoencephalopathy (83.1%), polyneuropathy (68.

View Article and Find Full Text PDF

Ptosis and proximal weakness may develop in multiple diseases including oculopharyngeal muscular dystrophy (OPMD) and myasthenia gravis (MG). These two entities can be challenging to differentiate since they may have important clinical and neurophysiological overlap. Systemic lupus erythematosus (SLE), a common autoimmune disease, has been described in association with MG.

View Article and Find Full Text PDF

The main objective was to document the differences between drinking times and oral perception between liquids in individuals with dysphagia. A second objective was to assess variations in consistency categorization across instruments. A third objective was to explore the relationship between drinking time and dysphagia severity.

View Article and Find Full Text PDF
Article Synopsis
  • Muscular dystrophy is a group of genetic disorders characterized by progressive muscle weakness, with Duchenne and Becker muscular dystrophies being X-linked conditions affecting dystrophin production.
  • Emery-Dreifuss muscular dystrophy is also X-linked, while facioscapulohumeral and oculopharyngeal muscular dystrophies are autosomal dominant disorders.
  • When providing anesthesia for dental patients with muscular dystrophy, it's essential to consider their cardiac and pulmonary health, avoid certain anesthetics like succinylcholine due to risks such as rhabdomyolysis, and use nondepolarizing neuromuscular blockers cautiously.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!